相关实验视频

Updated: Jul 17, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

苏蒂姆利马布用于冷凝固蛋白疾病

Mark Reid¹, Bethany A Fedutes Henderson²

¹From The James Cancer Hospital at The Ohio State University, Columbus, Ohio.

Journal of the advanced practitioner in oncology

|September 27, 2024

概括

感冒凝聚素疾病 (CAD) 是一种罕见的自身免疫性贫血. 苏提利马布是一种C1s抑制剂,通过改善血红蛋白,减少血液溶解和缓解患者的疲劳来有效治疗CAD.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

寒冷凝聚素疾病 (CAD) 是一种罕见的自身免疫血溶性贫血,与热抗体AIHA不同.
CAD的特点是补充介导的血液溶解,并且通常对皮质类固醇无反应.
在历史上,CAD的治疗选择包括具有可变反应的免疫疗法,并且这种情况会带来血栓形成和死亡的风险.

研究的目的:

为高级实践提供商 (APP) 提供CAD的全面概述.
专注于stimlimab作为CAD的新疗法选择.
为APP提供知识,以管理接受sitimlimab治疗的患者.

主要方法:

审查现有的医学文献关于CAD和 sutimlimab.
在CAD患者中对stimlimab进行III期临床试验数据的分析.
综合与APP在CAD管理中的实践相关的信息.

主要成果:

一种C1s抑制剂Sutimlimab在两项治疗CAD的III期研究中显示出有效性.
苏提利马布改善了关键指标,包括血红蛋白水平和血液溶解.
用stimlimab治疗的患者在疲劳方面经历了显著改善.

结论:

苏蒂姆利马布代表了冷凝素疾病的关键治疗进步.
补充抑制,特别是针对C1s,是CAD的一个可行的策略.
这篇文章是APP管理SAD患者的关键资源.

更多相关视频

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...